Clinical Trial Update: ThromboEmbolism Prevention Efficacy and Safety Trial (TEMPEST) [Phase 2]

View source ↗

Summary

A Phase 2 trial (TEMPEST) evaluating thromboembolism prevention in patients undergoing arthroplasty has completed, per the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthroplasty | Phase 2 | Status: COMPLETED